Effects of Polyphenols on Iron Absorption in Iron Overload Disorders.

Status Completed

Clinical Trial Summary

Dysmetabolic iron overload syndrome and genetic hemochromatosis are frequent causes of iron overload. Polyphenols are efficient iron-chelators. Investigator hypothesize that polyphenol supplementation can reduce iron absorption in iron overload disease. Iron absorption can be studied by the area-under-the-curve of serum iron after iron oral loading. The primary outcome is the decrease of post-prandial serum iron after rich-iron meal, due to polyphenol supplementation.

Clinical Trial Description

Iron overload diseases are highly prevalent. Dysmetabolic iron overload syndrome involves 15% of men with metabolic syndrome X. Genetic hemochromatosis is the most common genetic disease in Northern Europe. Both are due to a lack of regulation in iron absorption. To date, there is no nutritional study for those patients.

Polyphenols, particularly flavanols, have shown as good iron-chelating abilities as pharmacological chelators. However, no human study in iron-overload disease have been so far conducted.

The aim of POLYFER-study is to demonstrate that oral polyphenol intake reduces iron absorption in patients with genetic or metabolic iron-overload diseases.

POLYFER is a cross-over randomized controlled trial comparing the effect of polyphenol supplementation versus placebo on iron absorption after loading dose of iron given through a rich-iron meal. Iron absorption will be studied by the area under the curve of serum iron after the meal. Serum iron will be collected after the meal à 0 minute, 30 minutes, 1 hour, 2 hours, 3 hours et 4 hours.

Because of the nycthemeral variations of serum iron, it is essential to obtain a collection of serum iron data in the basal state (after fasting), allowing the calculation for each subject of a "relative" AUC after iron-rich meal with placebo and after iron-rich meal with polyphenols. The endpoint will be the difference between "relative" AUC after meal rich in iron alone and after polyphenols.

In order to improve the underlying mechanism of atherosclerosis which is highly prevalent in those diseases, we will conduct an ancillary study. Recent studies showed interesting results linking some oxylipins levels and inflammation. Investigator will study basal oxylipin level and post-prandial oxylipin level by lipidomic analysis in both diseases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03453918
Study type	Interventional
Source	University Hospital, Clermont-Ferrand
Contact
Status	Completed
Phase	N/A
Start date	April 9, 2018
Completion date	July 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03310203` - The Relation Between Adiposity, Inflammation, Glycaemia and Iron Absorption	N/A
Completed	`NCT01493297` - Effects of Vitamin A and Carotenoids on Iron Absorption	N/A
Active, not recruiting	`NCT02979132` - Iron Long-Term Labelling Study Switzerland	N/A
Completed	`NCT03586245` - Iron Absorption From Iron Enriched Aspergillus Oryzae in Females Using Stable Isotope Methodology	N/A
Completed	`NCT04774016` - Iron Absorption From an Iron-fortified Follow-up Formula With Added Synbiotic or Human Milk Oligosaccharides	N/A
Recruiting	`NCT06327529` - Zinc and Iron Absorption From Common Beans in Young Adult Women	N/A
Active, not recruiting	`NCT02977806` - Iron Long-Term Labelling Study Malawi
Completed	`NCT02197624` - Genetic Variants and Iron Absorption	N/A
Active, not recruiting	`NCT02979080` - Iron Long-Term Labelling Study Benin	N/A
Recruiting	`NCT05973552` - Iron Absorption and Requirements in Pregnancy and Lactation
Completed	`NCT03894358` - Iron Absorption From a Wheat-based Instant Cereal:Gut and Stable Isotope Studies in Kenyan Infants	N/A
Completed	`NCT01489007` - Iron Absorption in Vegetarian Children
Not yet recruiting	`NCT06236620` - Iron and Zinc Absorption in Flakes Derived From Sprouted or Hydrothermally Processed Wheat	N/A
Completed	`NCT05266703` - Defining the Serum Ferritin Concentration in Kenyan Women at Which the Body Senses Iron Depletion and Begins to Upregulate Iron Absorption	N/A
Completed	`NCT02228902` - Iron Absorption Trial	Phase 4
Completed	`NCT01423162` - Iron Bioavailability of Fortified Oat Drink	Phase 4
Completed	`NCT01483092` - Effect of Inulin on Iron Absorption in Humans	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Polyphenols on Iron Absorption in Iron Overload Disorders. — POLYFER

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms